ClinicalTrials.gov
ClinicalTrials.gov Menu

Botswana Pediatric Respiratory Disease and Bloodstream Infection Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00197691
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : April 2, 2012
Sponsor:
Information provided by (Responsible Party):
Harvard School of Public Health

Brief Summary:
The purpose of this study is to learn about lower respiratory tract and bloodstream diseases among infants born to HIV positive mothers in Botswana. Study factors include how commonly infants get these diseases, the causes, and outcomes. The study will also try to measure the protective effect, if any, of breast feeding on respiratory disease illness and deaths.

Condition or disease Intervention/treatment
HIV Infections Respiratory Tract Diseases Sepsis Procedure: blood draws, etc.

Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Botswana Pediatric Respiratory Disease and Bloodstream Infection
Study Start Date : March 2001
Actual Primary Completion Date : October 2005
Actual Study Completion Date : October 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS




Primary Outcome Measures :
  1. OCCURRENCE OF SUSPECTED PNEUMONIA OR BLOODSTREAM INFECTION OVER FIRST TWO YEARS OF LIFE [ Time Frame: Between birth and 2 years of life ]
    MORTALITY; EPISODES OF SUSPECTED PNEUMONIA; BACTEREMIA; PRESENCE OF NASOPHARYNGEAL VIRAL PATHOGENS; OROPHARYNGEAL COLONIZATION WITH BACTERIAL PATHOGENS



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
LIVEBORN INFANT IN THE MASHI PMTCT TRIAL
Criteria

Inclusion Criteria:

  • Participation in parent study, "Mashi" HIV vertical transmission prevention study for pregnant Botswana women and their infants

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00197691


Locations
Botswana
Princess Marina Hospital
Gaborone, Botswana
Sponsors and Collaborators
Harvard School of Public Health
Investigators
Principal Investigator: Shahin Lockman, MD Harvard School of Public Health

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Harvard School of Public Health
ClinicalTrials.gov Identifier: NCT00197691     History of Changes
Other Study ID Numbers: HSC 10027/000BOTS
First Posted: September 20, 2005    Key Record Dates
Last Update Posted: April 2, 2012
Last Verified: March 2012

Keywords provided by Harvard School of Public Health:
HIV infected mothers
Infants at risk of HIV-infection
Infant lower respiratory tract disease
Infant bloodstream infection

Additional relevant MeSH terms:
Infection
Communicable Diseases
HIV Infections
Respiration Disorders
Respiratory Tract Diseases
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases